Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2021 17:00 ET | Source: Harrow Health, Inc.

Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026

NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricing of...
April 14, 2021 16:01 ET | Source: Harrow Health, Inc.

Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones

NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced it has commenced an underwritten registered public...
April 14, 2021 16:00 ET | Source: Harrow Health, Inc.

Harrow Health Announces Preliminary First Quarter 2021 Financial Results

NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for...
March 08, 2021 16:01 ET | Source: Harrow Health, Inc.

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

Highlights for Fourth Quarter 2020: Revenues of $14.6 million, a 16% increase compared with $12.6 million for prior year;Adjusted EBITDA reached a new high of $4.0 million, compared with $2.1 million...
March 02, 2021 09:00 ET | Source: Harrow Health, Inc.

Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference

NASHVILLE, Tenn., March 02, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that Mark Baum, Chief Executive Officer, and Andrew...
February 25, 2021 09:00 ET | Source: Harrow Health, Inc.

Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

NASHVILLE, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the...
December 03, 2020 07:30 ET | Source: Harrow Health, Inc.

Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal

NASHVILLE, Tenn., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that a study featuring its patented MKO Melt® formulation has been published in the American...
November 20, 2020 07:30 ET | Source: Harrow Health, Inc.

Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference

NASHVILLE, Tenn., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that Mark Baum, Harrow’s Chief Executive Officer, and Andrew Boll, Harrow’s Chief Financial...
November 09, 2020 16:01 ET | Source: Harrow Health, Inc.

Harrow Health Publishes Third Quarter 2020 Letter to Stockholders

NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2020. Please click here to review Harrow Health’s Letter to...
October 27, 2020 07:30 ET | Source: Harrow Health, Inc.

Harrow Health to Announce Third Quarter 2020 Financial Results on November 9, 2020

NASHVILLE, Tenn., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, November 9, 2020, it will release third quarter 2020...